Effective treatment with omalizumab of a patient with spontaneous chronic urticaria and eosinophilic esophagitis.

This article reports the clinical history of a patient who had been affected by chronic spontaneous urticaria for 13 years, resistant to currently recommended therapy, and who was also diagnosed eosinophilic esophagitis. The anti-IgE monoclonal antibody omalizumab was rapidly effective and induced the clinical remission of both diseases.
PMID: 30265608 [PubMed - as supplied by publisher]

Source: Journal of Dermatological Treatment - September 30, 2018 Category: Dermatology Tags: J Dermatolog Treat Source Type: research